Ventilator-associated pneumonia in surgical emergency intensive care unit

• Published in: Saudi medical journal Vol. 27; no. 1; p. 52
• Main Authors: Ertugrul, Bulent M, Yildirim, Ayse, Ay, Pinar, Oncu, Serkan, Cagatay, Atahan, Cakar, Nahit, Ertekin, Cemalettin, Ozsut, Halit, Eraksoy, Haluk, Calangu, Semra
• Format: Journal Article
• Language: English
• Published: Saudi Arabia 01-01-2006
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; APACHE; Child; Child, Preschool; Cohort Studies; Female; Humans; Incidence; Infant; Intensive Care Units; Male; Middle Aged; Pneumonia - epidemiology; Pneumonia - etiology; Pneumonia - prevention & control; Respiration, Artificial - adverse effects; Risk Factors; Turkey; Wounds and Injuries - complications; Wounds and Injuries - surgery; Turkey
• ISSN: 0379-5284

To investigate the incidence, risk factors and the etiology of ventilator-associated pneumonia (VAP) in surgical emergency intensive care unit (ICU) patients.
We conducted this prospective cohort study in the surgical emergency ICU of Istanbul Medical Faculty between December 1999 and May 2001. We included 100 mechanically ventilated patients in this study. We diagnosed VAP according to the current diagnostic criteria. We identified the etiology of VAP cases by both quantitative cultures of endotracheal aspiration and blood cultures. To analyze the predisposing factors for the development of VAP, we recorded the following variables: age, gender, acute physiology and chronic health evaluation (APACHE) II score, Glasgow coma scale (GCS), sequential organ failure assessment (SOFA) score, serum albumin level, duration of mechanical ventilation (MV) prior to the development of VAP, and underlying diseases.
We determined the VAP incidence rate as 28%. We found the APACHE II score and the duration of MV to be statistically significant variables for the development of VAP. There were no significant differences regarding age, gender, GCS, SOFA score, albumin level, or underlying diseases for the development of VAP. The isolated bacteria among VAP cases were as follows: Staphylococcus aureus (n=12, 43%), Acinetobacter spp. (n=6, 21%), coagulase-negative Staphylococci (n=4, 15%), Pseudomonas aeruginosa (n=3, 10.7%) and Klebsiella pneumoniae (n=3, 10.7%).
Ventilator-associated pneumonia is a common infection, and certain interventions might affect the incidence of VAP. The ICU clinicians should be aware of the risk factors for VAP, which could prove useful in identifying patients at high risk for VAP, and modifying patient care to minimize the risk of VAP.